CARsgen Presents First Clinical Data on Its In Vivo CAR-T Product Candidate CT1182

1 hour ago

CARsgen Presents First Clinical Data on Its In Vivo CAR-T Product Candidate CT1182

SHANGHAI, Nov. 22, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces the clinical data from CT1182 (KJ-C2529), a CD19/CD20-targeting in vivo CAR T-cell product candidate developed on...

...

Read the fullstory

It's better on the More. News app

✅ It’s fast

✅ It’s easy to use

✅ It’s free

Start using More.
More. from PR Newswire ⬇️
news-stack-on-news-image

Why read with More?

app_description